DAVE vs. ANAB

Last updated Jun 9, 2026

DAVE (Dave Inc.) and ANAB (AnaptysBio, Inc.) are both stocks. DAVE operates in Software - Application (Technology), while ANAB operates in Biotechnology (Healthcare). Over the past 5 years, DAVE returned -3.13%/yr vs 26.26%/yr for ANAB. At a 0.14 correlation, their price movements are largely independent.

Performance

DAVE vs. ANAB - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Dave Inc. (DAVE) and AnaptysBio, Inc. (ANAB). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, DAVE achieves a 22.08% return, which is significantly lower than ANAB's 58.91% return.

DAVE

• 1D: 4.66%
• 1M: 5.45%
• YTD: 22.08%
• 6M: 33.54%
• 1Y: 22.00%
• 3Y*: 262.16%
• 5Y*: -3.13%
• 10Y*: —

ANAB

• 1D: 1.97%
• 1M: -25.92%
• YTD: 58.91%
• 6M: 73.08%
• 1Y: 225.06%
• 3Y*: 60.31%
• 5Y*: 26.26%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

DAVE vs. ANAB - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
DAVE Dave Inc.	22.08%	154.73%	936.61%	-9.64%	-97.17%	4.59%
ANAB AnaptysBio, Inc.	58.91%	266.16%	-38.19%	-30.88%	-10.82%	44.25%

Correlation

The correlation between DAVE and ANAB is 0.09, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.09
Correlation (3Y) Calculated over the trailing 3-year period	0.13
Correlation (5Y) Calculated over the trailing 5-year period	0.15
Correlation (All Time) Calculated using the full available price history since Apr 27, 2021	0.14

Fundamentals

Market Cap DAVE : $3.89B ANAB : $1.47B
EPS DAVE : $15.54 ANAB : -$0.91
PS Ratio DAVE : 7.10 ANAB : 6.51
PB Ratio DAVE : 19.10 ANAB : 115.60
Total Revenue (TTM) DAVE : $551.52M ANAB : $232.39M
Gross Profit (TTM) DAVE : $427.68M ANAB : $245.59M
EBITDA (TTM) DAVE : $165.95M ANAB : $52.72M

Return for Risk

DAVE vs. ANAB — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

DAVE

DAVE Risk / Return Rank: 53
DAVE Sharpe Ratio Rank: 53
DAVE Sortino Ratio Rank: 53
DAVE Omega Ratio Rank: 52
DAVE Calmar Ratio Rank: 54
DAVE Martin Ratio Rank: 52

ANAB

ANAB Risk / Return Rank: 95
ANAB Sharpe Ratio Rank: 96
ANAB Sortino Ratio Rank: 94
ANAB Omega Ratio Rank: 93
ANAB Calmar Ratio Rank: 96
ANAB Martin Ratio Rank: 96

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

DAVE vs. ANAB - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Dave Inc. (DAVE) and AnaptysBio, Inc. (ANAB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	DAVE	ANAB	Difference
Sharpe ratio: Return per unit of total volatility	0.30	3.29	-3.00
Sortino ratio: Return per unit of downside risk	0.92	3.69	-2.78
Omega ratio: Gain probability vs. loss probability	1.11	1.49	-0.38
Calmar ratio: Return relative to maximum drawdown	0.49	8.05	-7.56
Martin ratio: Return relative to average drawdown	0.88	20.07	-19.18
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

DAVE vs. ANAB - Sharpe Ratio Comparison

The current DAVE Sharpe Ratio is 0.30, which is lower than the ANAB Sharpe Ratio of 3.29. The chart below compares the historical Sharpe Ratios of DAVE and ANAB, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	DAVE	ANAB	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.30	3.29	-3.00
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.03	0.40	-0.44
Sharpe Ratio (All Time) Calculated using the full available price history	-0.03	0.23	-0.26

Drawdowns

DAVE vs. ANAB - Drawdown Comparison

The maximum DAVE drawdown since its inception was -99.01%, which is greater than ANAB's maximum drawdown of -92.08%. Use the drawdown chart below to compare losses from any high point for DAVE and ANAB.

Drawdown Indicators

	DAVE	ANAB	Difference
Max Drawdown Largest peak-to-trough decline	-99.01%	-92.08%	-6.93%
Max Drawdown (1Y) Largest decline over 1 year	-44.67%	-28.15%	-16.52%
Max Drawdown (3Y) Largest decline over 3 years	-44.67%	-69.32%	+24.65%
Max Drawdown (5Y) Largest decline over 5 years	-99.01%	-69.32%	-29.69%
Current Drawdown Current decline from peak	-40.93%	-40.07%	-0.86%
Average Drawdown Average peak-to-trough decline	-69.06%	-64.71%	-4.35%
Ulcer Index Depth and duration of drawdowns from previous peaks	24.93%	11.27%	+13.66%

Volatility

DAVE vs. ANAB - Volatility Comparison

Dave Inc. (DAVE) has a higher volatility of 18.37% compared to AnaptysBio, Inc. (ANAB) at 12.10%. This indicates that DAVE's price experiences larger fluctuations and is considered to be riskier than ANAB based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	DAVE	ANAB	Difference
Volatility (1M) Calculated over the trailing 1-month period	18.37%	12.10%	+6.27%
Volatility (6M) Calculated over the trailing 6-month period	48.81%	46.22%	+2.59%
Volatility (1Y) Calculated over the trailing 1-year period	73.92%	68.91%	+5.01%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	98.44%	65.30%	+33.14%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	97.30%	75.47%	+21.83%

Dividends

DAVE vs. ANAB - Dividend Comparison

Neither DAVE nor ANAB has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both DAVE and ANAB in my portfolio?

DAVE and ANAB have a correlation of 0.09, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, DAVE or ANAB?

DAVE has higher volatility (18.37%) compared to ANAB (12.10%). In terms of maximum drawdown, DAVE dropped -99.01% vs ANAB's -92.08%.

Which has better risk-adjusted returns?

ANAB currently has the higher Sharpe Ratio (3.29 vs 0.30), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.